Intranasal Use of Prescription Stimulants Among Adults Aged 18 to 30: Results From A Crowdsourcing Platform.
J Atten Disord
; 27(1): 14-25, 2023 01.
Article
em En
| MEDLINE
| ID: mdl-35904240
ABSTRACT
OBJECTIVE:
Few studies of prescription stimulant non-oral, non-medical use (NMU) (defined by use not as prescribed) have been conducted in adults beyond the college population. The purpose of this study was to characterize prescription stimulant non-oral use, specifically intranasal (IN) use (snorting) in young adults.METHOD:
Amazon's MTurk platform was used to recruit participants for an online survey. Data were collected from March to April 2020.RESULTS:
Thirty-two percent (n = 157) of survey respondents (N = 975), aged 18 to 30, reported IN prescription stimulant use (average of 32.1 episodes of lifetime IN use). Adderall was the most-reported prescription stimulant used intranasally (89.2%). Most IN users (82%; n = 68) reported spending no more than 5 minutes tampering with prescription stimulants. Intranasal users said they would take the medication orally if unable to tamper or manipulate medication for IN use.CONCLUSION:
These data help quantify a complex public health issue of ongoing IN use of prescription stimulants and suggest a potential role for manipulation-deterrent medications.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
2_ODS3
Base de dados:
MEDLINE
Assunto principal:
Transtorno do Deficit de Atenção com Hiperatividade
/
Transtornos Relacionados ao Uso de Substâncias
/
Crowdsourcing
/
Estimulantes do Sistema Nervoso Central
Limite:
Adult
/
Humans
Idioma:
En
Revista:
J Atten Disord
Ano de publicação:
2023
Tipo de documento:
Article